Skip to main content
. 2016 Jul 25;9:4583–4591. doi: 10.2147/OTT.S107272

Figure 1.

Figure 1

The discriminatory value of the IASLC/ATS/ERS classification, TNM-stage, or ten-gene signatures predicting the survival of the 91 patients with early-stage lung adenocarcinoma.

Notes: (A) Overall survival curve for the 91 cases of early-stage lung adenocarcinoma; (B) overall survival curves for patients grouped by the IASLC/ATS/ERS classification; (C) overall survival curves for patients grouped by the TNM stage; (D) overall survival curves for patients grouped by the risk score of ten-gene signatures.

Abbreviations: 5YS, 5-years survival; ATS, American Thoracic Society; ERS, European Respiratory Society; IASLC, International Association for the Study of Lung Cancer.